Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ARCO Arcos Dorados	$7.11 +1.6%	$7.34	$6.51 ▼ $10.27	$1.50B	0.59	1.61 million shs	1.45 million shs
PK Park Hotels & Resorts	$11.84 +6.0%	$10.75	$8.27 ▼ $16.23	$2.37B	1.8	3.92 million shs	4.23 million shs
TH Target Hospitality	$9.00 +1.7%	$7.69	$4.00 ▼ $11.10	$898.02M	1.92	471,730 shs	539,593 shs
THTX Theratechnologies	$3.26 +0.3%	$2.98	$1.12 ▼ $3.26	$149.90M	0.52	287,333 shs	112,840 shs

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ARCO Arcos Dorados	0.00%	-3.60%	-1.39%	-3.46%	-22.60%
PK Park Hotels & Resorts	0.00%	+8.48%	+5.62%	+16.14%	-21.88%
TH Target Hospitality	0.00%	+12.50%	+13.92%	+22.12%	-7.41%
THTX Theratechnologies	0.00%	+0.62%	+2.84%	+23.48%	+146.04%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ARCO Arcos Dorados	3.5304 of 5 stars	2.0	3.0	2.5	0.0	3.3	0.8	3.1
PK Park Hotels & Resorts	2.997 of 5 stars	1.0	1.0	2.5	2.4	3.4	1.7	1.3
TH Target Hospitality	1.8211 of 5 stars	3.5	1.0	0.0	0.0	2.5	1.7	0.0
THTX Theratechnologies	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ARCO Arcos Dorados	2.00	Hold	$8.80	23.86% Upside
PK Park Hotels & Resorts	2.09	Hold	$12.11	2.33% Upside
TH Target Hospitality	3.00	Buy	$13.00	44.44% Upside
THTX Theratechnologies	3.00	Buy	N/A	N/A

Current Analyst Ratings Breakdown

Latest TH, THTX, PK, and ARCO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/19/2025	TH Target Hospitality	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$7.50 ➝ $11.00
7/15/2025	PK Park Hotels & Resorts	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform
7/3/2025	THTX Theratechnologies	Jones Trading Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
7/2/2025	ARCO Arcos Dorados	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral	$10.50 ➝ $8.80
7/1/2025	PK Park Hotels & Resorts	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$10.00 ➝ $11.00
6/23/2025	PK Park Hotels & Resorts	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Underweight	$10.00
5/30/2025	PK Park Hotels & Resorts	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	$16.00 ➝ $11.00

(Data available from 8/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ARCO Arcos Dorados	$4.47B	0.33	$1.55 per share	4.59	$2.42 per share	2.94
PK Park Hotels & Resorts	$2.60B	0.91	$2.47 per share	4.80	$17.41 per share	0.68
TH Target Hospitality	$386.27M	2.32	$1.49 per share	6.06	$4.26 per share	2.11
THTX Theratechnologies	$85.87M	1.75	N/A	N/A	($0.55) per share	-5.93

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ARCO Arcos Dorados	$148.76M	$0.63	11.28	9.73	1.39	2.89%	24.54%	4.10%	11/12/2025 (Estimated)
PK Park Hotels & Resorts	$212M	$0.27	43.83	5.36	N/A	2.25%	0.76%	0.30%	11/4/2025 (Estimated)
TH Target Hospitality	$71.26M	$0.10	90.00	25.00	N/A	3.58%	3.26%	2.13%	11/11/2025 (Estimated)
THTX Theratechnologies	-$8.31M	-$0.19	N/A	46.57	N/A	-10.85%	N/A	-9.83%	10/9/2025 (Estimated)

Latest TH, THTX, PK, and ARCO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2025	Q2 2025	ARCO Arcos Dorados	$0.05	$0.11	+$0.06	$0.11	$1.22 billion	$1.14 billion
8/7/2025	Q2 2025	TH Target Hospitality	-$0.11	-$0.15	-$0.04	-$0.15	$56.43 million	$61.61 million
7/31/2025	Q2 2025	PK Park Hotels & Resorts	$0.57	$0.64	+$0.07	$0.64	$672.37 million	$672.00 million
7/9/2025	Q2 2025	THTX Theratechnologies	-$0.01	-$0.09	-$0.08	-$0.09	$24.30 million	$17,729.00 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ARCO Arcos Dorados	$0.24	3.38%	N/A	38.10%	1 Years
PK Park Hotels & Resorts	$1.00	8.45%	N/A	370.37%	1 Years
TH Target Hospitality	N/A	N/A	N/A	N/A	N/A
THTX Theratechnologies	N/A	N/A	N/A	N/A	N/A

Latest TH, THTX, PK, and ARCO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/1/2025	PK Park Hotels & Resorts	quarterly	$0.25	9.7%	9/30/2025	9/30/2025	10/15/2025
6/18/2025	ARCO Arcos Dorados		$0.06	3.13%	6/24/2025	6/25/2025	6/27/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ARCO Arcos Dorados	1.62	0.80	0.73
PK Park Hotels & Resorts	1.35	1.16	1.16
TH Target Hospitality	0.07	1.47	1.47
THTX Theratechnologies	N/A	0.84	0.65

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ARCO Arcos Dorados	55.91%
PK Park Hotels & Resorts	92.69%
TH Target Hospitality	32.40%
THTX Theratechnologies	N/A

Insider Ownership

Company	Insider Ownership
ARCO Arcos Dorados	N/A
PK Park Hotels & Resorts	1.90%
TH Target Hospitality	68.00%
THTX Theratechnologies	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ARCO Arcos Dorados	98,615	210.65 million	N/A	Optionable
PK Park Hotels & Resorts	90	199.91 million	196.12 million	Optionable
TH Target Hospitality	820	99.78 million	31.93 million	Not Optionable
THTX Theratechnologies	140	45.98 million	N/A	Optionable

TH, THTX, PK, and ARCO Headlines

Recent News About These Companies

Theratechnologies Inc. (NASDAQ:THTX) Sees Significant Drop in Short Interest

August 23 at 2:14 AM | marketbeat.com

Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak

August 18, 2025 | globenewswire.com

Theratechnologies (NASDAQ:THTX) Trading Down 0.3% - Here's What Happened

July 31, 2025 | marketbeat.com

Theratechnologies Reports Financial Results for the Second Quarter 2025

July 9, 2025 | globenewswire.com

Theratechnologies: Beyond GLP-1s - Is Tesamorelin's Exit A Sign Of New Metabolic Opportunities?

July 7, 2025 | seekingalpha.com

Future Pak to buy Theratechnologies for $254 million

July 4, 2025 | thepharmaletter.comT

Theratechnologies Stock (NASDAQ:THTX), Insider Trading Activity

July 3, 2025 | benzinga.com

Theratechnologies Inc. (THTX) - Yahoo Finance

July 3, 2025 | finance.yahoo.com

Theratechnologies Stock Short Interest Report | NASDAQ:THTX - Benzinga

July 3, 2025 | benzinga.com

Theratechnologies shareholders should take the deal, Research Capital says

July 3, 2025 | cantechletter.comC

Theratechnologies to be bought by CB Biotechnology for $254M

July 3, 2025 | msn.com

Theratechnologies to Announce Second Quarter 2025 Financial Results

July 3, 2025 | globenewswire.com

Theratechnologies to be Acquired by Future Pak Affiliate

July 2, 2025 | tipranks.com

Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak

July 2, 2025 | finance.yahoo.com

Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak

July 2, 2025 | globenewswire.com

Theratechnologies Reports on its Annual Meeting of Shareholders

May 29, 2025 | globenewswire.com

Theratechnologies announces annual shareholder meeting

May 4, 2025 | uk.investing.com

Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV

May 2, 2025 | globenewswire.com

Theratechnologies: A High-Risk, High-Reward Speculation As Shares Trade At 39% Discount To Future Pak's $3.51-$4.50 Offer

April 18, 2025 | seekingalpha.com

Is Theratechnologies Inc. (THTX) the Best Rising Penny Stock to Buy According to Analysts?

April 18, 2025 | msn.com

Theratechnologies to further evaluate potential sale of the company

April 16, 2025 | markets.businessinsider.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

TH, THTX, PK, and ARCO Company Descriptions

Arcos Dorados NYSE:ARCO

$7.10 +0.12 (+1.65%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$7.12 +0.01 (+0.14%)

As of 08/22/2025 07:44 PM Eastern

Arcos Dorados Holdings Inc. operates as a franchisee of McDonald's restaurants. It has the exclusive right to own, operate, and grant franchises of McDonald's restaurants in 20 countries and territories in Latin America and the Caribbean, including Argentina, Aruba, Brazil, Chile, Colombia, Costa Rica, Curacao, Ecuador, French Guiana, Guadeloupe, Martinique, Mexico, Panama, Peru, Puerto Rico, Trinidad and Tobago, Uruguay, the U.S. Virgin Islands of St. Croix and St. Thomas, and Venezuela. The company was founded in 2007 and is based in Montevideo, Uruguay.

Park Hotels & Resorts NYSE:PK

$11.84 +0.67 (+5.95%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$11.84 +0.00 (+0.03%)

As of 08/22/2025 07:50 PM Eastern

Park Hotels & Resorts, Inc. operates as a real estate investment trust, which owns and operates hotels and resorts. It operates through the Consolidated Hotels and Unconsolidated Hotels segments. Its portfolio of hotels and resorts include the Waldorf Astoria Hotels and Resorts, Conrad Hotels & Resorts, Hilton Hotels & Resorts, DoubleTree by Hilton, Embassy Suites by Hilton, Hilton Garden Inn, Hampton by Hilton, and Curio. The company was founded by Conrad Hilton in 1919 and is headquartered in Tysons, VA.

Target Hospitality NASDAQ:TH

$9.00 +0.15 (+1.69%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$9.00 0.00 (0.00%)

As of 08/22/2025 07:50 PM Eastern

Target Hospitality Corp. operates as a specialty rental and hospitality services company in North America. The company operates through two segments, Hospitality & Facilities Services - South and Government. It owns a network of specialty rental accommodation units. In addition, the company provides catering and food, maintenance, housekeeping, grounds-keeping, security, health and recreation facilities, workforce community management, concierge, and laundry services. It serves the U.S. government contractors and investment grade natural resource development companies. Target Hospitality Corp. was founded in 1978 and is headquartered in The Woodlands, Texas.

Theratechnologies NASDAQ:THTX

$3.26 +0.01 (+0.31%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$3.25 -0.01 (-0.31%)

As of 08/22/2025 05:15 PM Eastern

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its pipeline products include F8 Formulation that is in Phase 2b/3 clinical trials for studying tesamorelin for the treatment of nonalcoholic steatohepatitis; multi -dose pen injector for the administration of tesamorelin; SORT1+ Technology Platform for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; Sudocetaxel Zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time